Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study of the Pharmacokinetics of Intravenous and Oral Amisulpride in Adults With Severe Renal Impairment and Healthy Control Subjects

NCT04849650 is registered in ClinicalTrials.gov with Acacia Pharma Ltd as lead sponsor.

NCT NCT04849650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04849650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study of the Pharmacokinetics of Intravenous and Oral Amisulpride in Adults With Severe Renal Impairment and Healthy Control Subjects
Lead sponsor
Acacia Pharma Ltd
Phase
Phase 1
Overall status
Completed
Start date
June 3, 2021
Completion date
October 30, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal disease, end stage